Benchmark Financial Wealth Advisors, LLC Amgen Inc Transaction History
Benchmark Financial Wealth Advisors, LLC
- $311 Million
- Q4 2024
A detailed history of Benchmark Financial Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Benchmark Financial Wealth Advisors, LLC holds 770 shares of AMGN stock, worth $252,067. This represents 0.06% of its overall portfolio holdings.
Number of Shares
770
Previous 1,162
33.73%
Holding current value
$252,067
Previous $374,000
46.52%
% of portfolio
0.06%
Previous 0.12%
Shares
6 transactions
Others Institutions Holding AMGN
# of Institutions
3,177Shares Held
419MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$17.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.64 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.77 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.32 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $175B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...